Tori Rodriguez, MA, LPC, AHC

Elizabeth Profita, MD, and Gerard J. Boyle, MD, FACC, discuss myocarditis in younger populations and how pediatric cardiologists should respond with treatment.

In a Q&A, Asher Schranz, MD, MPH, discusses the importance of physician collaboration in the treatment of patients with drug use-associated infective endocarditis.

Anum Minhas, MD, and Jason Vaught, MD, discuss the need to address valvular diseases during pregnancy and how a strong collaboration between obstetricians and cardiologists can help.

Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.

Recent research and an interviews with cardiologists highlight health disparities in heart failure care.

A review by Ebrahimi and colleagues, and an interview with Beth Cohen, MD, highlights the possible mechanisms driving the association between posttraumatic stress disorder and cardiovascular disease, and the need for screening and treatment options for these patients.

A significant number of cases of post-COVID-19 myocarditis have been reported.

To discuss the potential factors driving the increasing alcohol use among women as well as potential solutions, we interviewed David Streem, MD, and Leena P. Mittal, MD, FACLP.

Since pulse oximetry technology was developed in nondiverse populations, racial bias may influence the accuracy of pulse oximeter readings.

Cardiologists around the world report experiencing harassment and discrimination in the workplace.